07.12.2017
- The US Food and Drug Administration (FDA) has given the green light to Netherlands-domiciled, US-managed generic drugmaker Mylan’s Ogivri (trastuzumab-dkst) breast cancer drug, a...
24.11.2017
- In a suit filed in the state of Delaware, the Swiss-based Roche Holding is suing Pfizer to block the future marketing a biosimilar of its breast-cancer drug Herceptin in the US...
21.11.2017
- European pharmaceutical industry heavyweights Novartis and Bayer are challenging a proposal by parts of the UK’s National Health Service (NHS) to allow patients with wet age...
30.10.2017
- As antibiotic resistance becomes an increasingly urgent threat to public health, pharmaceutical firms Roche and Warp Drive Bio have joined forces to develop novel classes of the...
19.10.2017
- A lawsuit filed in the US capital of Washington, DC this week alleges that bribes it says were paid by leading drugmakers including Pfizer, Roche, Johnson & Johnson and AstraZeneca...
18.10.2017
- As generics pricing pressure increases, Swiss drugmaker Novartis said it will close a US plant at Broomfield, Colorado, owned by its Sandoz subsidiary and employing 450 people. It...
27.09.2017
- Pharma Waldhof is active in the development and commercialization of active substances, key intermediates and reagents for multiple applications in the pharmaceutical, diagnostics...
16.08.2017
- US biotech Dermira has agreed to license certain rights from Swiss drugmaker Roche and its subsidiary Genentech for the investigational atopic dermatitis drug, lebrikizumab. The...
